Sign in

CIK 0001439222 · Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Option exercise Director acquired 1,976 shares (option exercise)
  2. 4 Option exercise Director acquired 1,976 shares (option exercise)
  3. 4 Planned sale Chief Legal Officer sold 3,280 shares at $34.71 ($113,849)
  4. 4 Planned sale Chief Medical Officer sold 2,940 shares at $34.71 ($102,047)
  5. 4 Planned sale Chief Financial Officer sold 3,141 shares at $34.71 ($109,024)
  6. 4 Planned sale Chief Commercial Officer sold 3,262 shares at $34.71 ($113,224)
  7. 4 Planned sale Chief Corp Dev & Strategy sold 2,959 shares at $34.71 ($102,707)
  8. 4 Planned sale Chief Executive Officer sold 19,068 shares at $34.71 ($661,850)
  9. 4 Planned sale Chief Corp Dev & Strategy sold 2,959 shares at $27.80 ($82,260)
  10. 4 Open-market sale Principal Accounting Officer sold 5,272 shares at $28.88 ($152,255)
  11. 4 Planned sale Chief Executive Officer sold 18,055 shares at $28.96 ($522,873)
  12. 4 Planned sale Chief Legal Officer sold 5,218 shares at $28.96 ($151,113)
  13. 4 Planned sale Chief Medical Officer sold 4,055 shares at $28.96 ($117,433)
  14. 4 Planned sale Chief Financial Officer sold 5,035 shares at $28.96 ($145,814)
  15. 4 Planned sale Chief Commercial Officer sold 2,868 shares at $28.96 ($83,057)
  16. 4 Planned sale Principal Accounting Officer sold 2,223 shares at $28.96 ($64,378)
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Chief Commercial Officer sold 2,872 shares at $27.02 ($77,601)
  19. 4 Planned sale Chief Legal Officer sold 2,932 shares at $27.09 ($79,428)
  20. 4 Planned sale Chief Executive Officer sold 18,703 shares at $27.09 ($506,664)

Page 2 of 38 · 758 filings